GLP-1减肥药可能会阻碍肠道准备内镜手术. GLP-1 weight-loss medications may hinder bowel preparation for endoscopic procedures.
研究表明,GLP-1类减重药物,如Ozempic和Wegovy,可能妨碍肠胃准备内皮程序,增加准备不足的风险,并可能影响程序结果。 Research indicates that GLP-1 weight-loss medications like Ozempic and Wegovy may hinder bowel preparation for endoscopic procedures, increasing the risk of inadequate preparation and potentially affecting procedure outcomes. 一项研究发现,与非使用者相比,服用这些药物的患者的食物和便保留率更高. A study found that patients on these medications had higher instances of food and stool retention compared to non-users. 需要进一步调查,以评估是否应对使用GLP-1药物的病人修改肠胃准备准则。 Further investigation is needed to assess whether bowel prep guidelines should be revised for patients using GLP-1 drugs.